This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

Started to move north again.

cheers Gf

Broker note anyone?.

cheers GF.

Its been delayed for 3 weeks....

Some big news coming out then?.

cheers Gf

Yes thats right but we will have to wait at least 3 weeks..

Thanks Mitzy, please keep us informed here with any info, seen you on the other big site, but please dont forget us.

cheers GF

what affect do you think the recent news will have on the company has a whole ?

RNS Number:8144C
Medical Marketing Int'l Group PLC
10 September 2004

FOR IMMEDIATE RELEASE 10TH SEPTEMBER 2004



MMI ANNOUNCES FURTHER LABHOTEL(R) PARTNER


Medical Marketing International Group plc (MMI) (LSE:MMG) the Cambridge,
UK-based biopharmaceutical development company focussed on cancer, AIDS and
'superbugs' announces that it has reached an exclusive agreement with Corbett
Research, an Australian Biotechnology company at the forefront of the
development of genetic analysis laboratory equipment, to supply its systems to
MMI's LabHotel(R).

LabHotel(R) has a unique business model as it provides fledgling biotechnology
companies based at MMI's Bioscience Innovation Centre (BIC) in Cambridge, UK,
access to sophisticated equipment managed to industrial standards on a
short-term rental basis rather than incurring capital costs. LabHotel(R) already
contains laboratories dedicated to tissue culture, microbiology and protein
purification services with further services in the pipeline.

David Best, Chairman of MMI, explained: "We are delighted that another leader,
Corbett Research is supporting our LabHotel(R). The capital cost of equipment is
often prohibitive resulting in emerging biotech companies being unable to
generate quality data that will satisfy themselves, potential partners and
investors. MMI's LabHotel(R) solves this problem by enabling the manufacturers of
world-class equipment to install their systems in a professionally managed
purpose-built centre. Through this innovative service we believe that we will
increase occupancy as well as fee levels and create greater opportunities for
MMI to take advantage of investing in these exciting businesses as well as
providing essential facilities for our in-house biobabies. Our goal is that
LabHotel(R) becomes the centre of excellence for biotechnology".

John Corbett, Director of Corbett Research commented: "This innovative approach
provides excellent opportunities for start-up companies wanting proof of
principle. The Lab Hotel is the ideal venue for us as an organisation to
showcase our latest equipment and to work with emerging companies to help them
develop new technologies"

A good deal thanks for posting it Mick.

cheers GF.

Should have a good week after a strong finishing week to techs in the US and also broker upgrades across there.

cheers GF.

How close are we to Medical Marketing shares taking off. I have been waiting for the broker update and a rapid move north this week. Any news would be much appreciated.

Jacks, Have to say it as become a little frustrating especially after a bad day on Friday.

Im sure we will get good news very soon.

cheers GF.

Still nothing but it will come.

cheers Gf.

Mitzy,

You've gone quiet, is there a problem? Are MMG still be recommended as a strong buy? If so what's happened this week?
I'm not overly worried as I've been in since March and this share is up and down like a kangaroo on a spacehopper and I also believe pipeline iis such that potentially big rewards but having topped up in recent weeks it's a tad annoying to see these in the red or more to the point could have got more this week for the same dosh!
What news on the brokers note?

Andy

No idea Andy I wish I knew but I really dont..a few sells today set off further stop losses as people panicked.We have the Agm mid Oct and a brokers note is due around about then; also results are due soon but have been delayed for some reason.Still holding for now and see what the Agm has to offer..

Keep calm ANDY.

things will GO our way.

Cheerrs GF

Medical Marketing raise 2.3 mln stg to fund product development
AFX


LONDON (AFX)- Medical Marketing International Group PLC, said it has raised 2.3 mln stg following a placing of 3.35 mln shares, at a price of 0.70 pence each.

The funds are to be used to support the clinical trials process of its products, the company said.

newsdesk@afxnews.com

Thats a lot of money to raise but they have managed to pull it off...they must be fairly confident of that oncosense will succeed in phase 2 trials.

Do you think the share price drop was "manufactured" to below 70p to allow the Institutions putting up the dosh to get a good price?
If, so is it likely to stay below 70p until the AGM approves it and if so looks like another good buying opportunity for all of us following this one.

What do you reckon?

Either way glad the drop doesn't look like bad news, you don't get 2.3m if the future is bleak!

Final Results are due next week apparently and the Agm in another 3 weeks...its all good news as far as the placing goes as it means phase 2 trials can start in ernest with the funding in position.Michael Walters has a latest post on the fundraising.